Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06366802
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-02-01
Brief Title:
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
The First Affiliated Hospital of Soochow University
Study Overview
Official Title:
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multiple myeloma MM is a disease caused by malignant plasma cell proliferation disorder Survival outcomes continue to vary widely even within uniformly treated clinical trial populations How to construct a clinical prognosis model of MM through real-world data to guide the selection of treatment options standardize patient management and improve survival expectations is a major problem that needs to be solved urgently It is necessary to build an MM-specific cohort in China to comprehensively understand the characteristics of MM patients explore treatment options and improve prognostic factors for survival outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None